Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hussein Arkhagha. Director active across 1 company, notably Hikma Pharmaceuticals PLC. Cumulatively, 13 filings have been published. Activity tracked since 3 May 2024. The latest transaction was disclosed on 5 May 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Declarations 13 total
0
GB00B0LCW083⌘ RNS:9597628-4 Ideal exit: 26 Feb 2027 (T+270) 41,037 shares GB00B0LCW083⌘ RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-4 Ideal exit: 26 Feb 2027 (T+270) 407 shares @ £14.098 6.3% of flow GB00B0LCW083⌘ RNS:549f9a76-e199-4690-8f52-59ddfd93c657-0 Ideal exit: 30 Jan 2027 (T+270) 59,221 shares GB00B0LCW083⌘ RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-3 6,200 shares @ £12.00 86.9% of flow GB00B0LCW083⌘ RNS:9eb3f15e-d27a-4228-8316-e3ccca55608f Ideal exit: 4 Dec 2026 (T+270) 260 shares @ £16.30 37.5% of flow GB00B0LCW083⌘ RNS:5832371-2 Ideal exit: 19 Jun 2026 (T+270) 15,983 shares GB00B0LCW083⌘ RNS:5680033-6 Ideal exit: 24 Feb 2026 (T+270) 46,913 shares GB00B0LCW083⌘ RNS:5613092-6 8,675 shares GB00B0LCW083⌘ RNS:5560504-6 Ideal exit: 25 Nov 2025 (T+270) 206 shares @ £19.03 58.1% of flow GB00B0LCW083⌘ RNS:5361694-1 Ideal exit: 20 Jun 2025 (T+270) 447 shares @ £19.34 100.0% of flow GB00B0LCW083⌘ RNS:5176047-2 Ideal exit: 28 Jan 2025 (T+270) 46,546 shares GB00B0LCW083⌘ RNS:5139884-7 15,843 shares GB00B0LCW083⌘ RNS:5103062-6 Ideal exit: 7 Dec 2024 (T+270)